G M Samaras|J F Contrera - JoVE Visualize

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Surgery|August 1, 1982

Aggressive multimodality therapy based on a multicompartmental model of glioblastomaM Salcman, R S Kaplan, G M Samaras, et al.

Bioelectromagnetics|January 1, 1981

Dielectric properties of animal tissues in vivo at frequencies 10 MHz--1 GHzM A Stuchly, T W Athey, S S Stuchly, et al.

Journal of Neuro-Oncology|January 1, 1984

Removable high intensity iridium-192 brain implants. Technique and in vivo measurements in canine brainW Sewchand, P P Amin, R E Drzymala, et al.

Endocrinology|June 1, 1991

Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in ratsN M Appel, M J Owens, S Culp, et al.

Toxicologic Pathology|August 26, 1998

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotypeJ L Weaver, J F Contrera, B A Rosenzweig, et al.

Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Surgery|August 1, 1982

Aggressive multimodality therapy based on a multicompartmental model of glioblastomaM Salcman, R S Kaplan, G M Samaras, et al.

Bioelectromagnetics|January 1, 1981

Dielectric properties of animal tissues in vivo at frequencies 10 MHz--1 GHzM A Stuchly, T W Athey, S S Stuchly, et al.

Journal of Neuro-Oncology|January 1, 1984

Removable high intensity iridium-192 brain implants. Technique and in vivo measurements in canine brainW Sewchand, P P Amin, R E Drzymala, et al.

Endocrinology|June 1, 1991

Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in ratsN M Appel, M J Owens, S Culp, et al.

Toxicologic Pathology|August 26, 1998

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotypeJ L Weaver, J F Contrera, B A Rosenzweig, et al.

Pageof 3